Parallel Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Parallel Advisors, LLC

$3.67 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	SELL	$98.98 - $115.74 $296 - $347	-3 Reduced 0.66%	454 $52,000
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $296 - $347	-3 Reduced 0.66%	454 $52,000
Q1 2023 May 20, 2024	BUY	$107.32 - $113.5 $49,045 - $51,869	457 New	457 $49,000
Q4 2022 Feb 03, 2023	SELL	$62.39 - $113.8 $249 - $455	-4 Reduced 0.87%	457 $52,000
Q3 2022 Nov 10, 2022	BUY	$58.92 - $84.67 $9,839 - $14,139	167 Added 56.8%	461 $29,000

Q2 2022 Aug 01, 2022	SELL	$79.4 - $116.36 $9,051 - $13,265	-114 Reduced 27.94%	294 $23,000
Q1 2022 Apr 28, 2022	BUY	$86.42 - $109.81 $14,000 - $17,789	162 Added 65.85%	408 $43,000
Q4 2021 Jan 20, 2022	SELL	$98.56 - $119.91 $8,180 - $9,952	-83 Reduced 25.23%	246 $27,000
Q3 2021 Nov 02, 2021	BUY	$91.91 - $110.37 $6,893 - $8,277	75 Added 29.53%	329 $36,000
Q2 2021 Aug 06, 2021	BUY	$86.24 - $95.92 $2,242 - $2,493	26 Added 11.4%	254 $24,000
Q1 2021 Apr 23, 2021	BUY	$71.83 - $95.48 $7,973 - $10,598	111 Added 94.87%	228 $21,000
Q4 2020 Feb 02, 2021	BUY	$67.0 - $84.39 $1,340 - $1,687	20 Added 20.62%	117 $9,000
Q3 2020 Oct 27, 2020	BUY	$55.23 - $79.93 $2,209 - $3,197	40 Added 70.18%	97 $8,000
Q2 2020 Jul 16, 2020	SELL	$30.2 - $56.98 $151 - $284	-5 Reduced 8.06%	57 $3,000
Q1 2020 Apr 27, 2020	BUY	$24.87 - $38.56 $124 - $192	5 Added 8.77%	62 $1,000
Q4 2019 Jan 30, 2020	SELL	$25.43 - $36.67 $26,650 - $38,430	-1,048 Reduced 94.84%	57 $2,000
Q3 2019 Nov 01, 2019	BUY	$23.0 - $27.97 $1,104 - $1,342	48 Added 4.54%	1,105 $30,000
Q2 2019 Aug 05, 2019	BUY	$22.81 - $28.48 $24,110 - $30,103	1,057 New	1,057 $25,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account